William Kielbasa

Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism

David T. George, Jodi M. Gilman, Jacqueline Hersh et al. · Science · 2008 · 212 citations

Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2

Nicholas Seneca, Balázs Gulyás, Andrea Varrone et al. · Psychopharmacology · 2006 · 77 citations

Dose-dependent Fashion, Neurophysiology, Medicine +9

Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder

Johannes Tauscher, William Kielbasa, Smriti Iyengar et al. · European Neuropsychopharmacology · 2009 · 56 citations

Psychiatry, Medicine, Psychopharmacology +11

Safety of galcanezumab in patients with episodic migraine: A randomized placebo-controlled dose-ranging Phase 2b study

Tina M. Oakes, Vladimir Skljarevski, Qi Zhang et al. · Cephalalgia · 2018 · 50 citations

Exploratory Translational Modeling Approach in Drug Development to Predict Human Brain Pharmacokinetics and Pharmacologically Relevant Clinical Doses

William Kielbasa, Robert E. Stratford · Drug Metabolism and Disposition · 2012 · 44 citations